Skip to main content
Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Melan-Gnas1 cell line

Target:

Sub-type:

Host:

Application: Melanocyte cell biology

 £575.00
£575.00
× Placeholder FLYA-13 Cell Line

Target:

Sub-type: Continuous

Host:

Application:

Cat. #151655

 £575.00
£575.00
× Figure 1. The family tree of A2780 cell sublines with acquired resistance to PTX. A2780 parental cell line and six sublines; chosen for further studies; are bolded. The schedule of PTX treatment for each cell line is described as e.g. (4+7+27)d* - 4 days of 2 nM PTX treatment; 7 days of recovery and 27 days of 2 nM PTX retreatment; totally 31 days of drug treatment were needed for cell adaptation to 2 nM PTX concentration. Reprinted from Szenajch J. et al. 2020. Int. J. Mol. Sci. 21(23) A2780 PTX(128) resistant cell line

Target: Paclitaxel resistance

Sub-type: Continuous

Host:

Application:

Cat. #160734

 £575.00
£575.00
× 2fTGH Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC) 2fTGH Cell Line

Target: IFNg signalling mutants,alpha interferon signalling pathway, IFN regulated human gene 6-16

Sub-type: Continuous

Host:

Application:

Cat. #151484

 £575.00
£575.00
× MEF Raf1 FF/FF KI Cell Line. Early log phase. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK. MEF Raf1 FF/FF KI Cell Line

Target: Raf1 Y340F Y341F inactive mutant

Sub-type:

Host:

Application:

Cat. #151629

 £575.00
£575.00
× Placeholder Melan-Ink4a-Arf4 cell line

Target:

Sub-type:

Host:

Application: Melanocyte cell biology

 £575.00
£575.00

Cart totals

Subtotal £3,450.00
Shipping

Shipping options will be updated during checkout.

Total £3,660.00
Proceed to checkout

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.